The Prostate · 2017 · 29 citations · 25 references
MedicineOncologyUrologyCarcinogenesisNeoplasiaReproductive EndocrinologyHormonal Cancer TherapyHormonal TherapyHormone-related CarcinogenesisProstate CancerProstate PathologyProstatic PathologyAndrogen Receptor ExpressionAndrogen ReceptorsEstrogen ReceptorsEstrogen-dependent CarcinogenesisProstate AdenocarcinomaProstate Cancer Hormonal TherapyProstatic AdenocarcinomaRodent Tumor Models
BACKGROUND: Prostate adenocarcinoma (PCa) is a rare diagnosis in the male to female transgender (MtFT) population with only a few case reports published in the current medical literature. Long standing beliefs of androgen suppression conferring a protective effect against prostate cancer development have been challenged by the literature citing adenocarcinoma development in the prostate of rodent models following combined estrogen and testosterone treatment. MATERIALS AND METHODS: We herein present a MtFT patient who presented with high grade PCa following 20 years of exogenous estrogen therapy. RESULTS: Immunohistochemical (IHC) localization of estrogen receptor alpha (ER-α) and progesterone receptor (PR) demonstrated positive staining in stromal cells; while, androgen receptor (AR) demonstrated positive staining in malignant glands and weak scattered staining in adjacent stroma. CONCLUSION: This pattern of staining raises concern for a possible contributing role of exogenous estrogen therapy in tumorigenesis. As awareness of gender dysphoria and acceptance of gender reassignment surgery has seen a recent increase, the unique needs of this population must be recognized. Prostate 77:824-828, 2017. © 2017 Wiley Periodicals, Inc.
25
Daniel D. Murray, Kazuo Suzuki, Matthew Law et al. · PLoS ONE · 2015 · 2.7K citations · Full text
Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease
Valentina Escott‐Price, Céline Bellenguez, Li‐San Wang et al. · PLoS ONE · 2014 · 1.4K citations · Full text
Irwin Leav, Kin‐Mang Lau, Jason Y. Adams et al. · American Journal Of Pathology · 2001 · 392 citations · Full text
Frequent loss of estrogen receptor-beta expression in prostate cancer.
Lisa G. Horvath, Susan M. Henshall, C S Lee et al. · PubMed · 2001 · 305 citations